A 52-year-old woman who experienced a myocardial infarction during treatment for depression with mirtazapine

Kyoung Sae Na, Bun Hee Lee, Yong Ku Kim, Changsu Han

Research output: Contribution to journalArticle


Patients with depression and cardiovascular disease must be monitored carefully during pharmacotherapy because their depressive symptoms and/or antidepressant medications may have a negative impact on heart function. Mirtazapine is considered a safe and effective antidepressant drug used in the treatment of cardiovascular and other systemic diseases. This report, however, documents a case of myocardial infarction that appeared to be associated with mirtazapine administration.

Original languageEnglish
Pages (from-to)45-46
Number of pages2
JournalClinical Psychopharmacology and Neuroscience
Issue number1
Publication statusPublished - 2006 Aug 1



  • Depression
  • Heart
  • Mirtazapine
  • Myocardial infarction

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Pharmacology (medical)

Cite this